CFAR offered a general Pilot Award program from 1994 to 2017 and funded 82 early stage investigators.
In 2022, CFAR initiated a new program: Pilot Award for Investigators New to HIV.
82 Awards
-
Property Rights and HIVIAIDS Prevention: Examining the Impact of a Community Land and Property WatchDog Model In Nyanza and Western Provinces, Kenya
Property Rights and HIVIAIDS Prevention: Examining the Impact of a Community Land and Property WatchDog Model In Nyanza and Western Provinces, Kenya
Abstract
Poverty and gender inequality are two core structural factors that shape women's vulnerability to HIV/AIDS. Recent research demonstrates that access to and control over assets such as property can empower women, provide them with a secure means of livelihood, prevent food insecurity, and improve household bargaining power, all of which mitigate the negative effects of HIV/AIDS. However, little work has intervened at the intersection of property rights and HIV/AIDS prevention.
-
Barriers to Timely HIV Testing and Treatment
Barriers to Timely HIV Testing and Treatment
Abstract
-
Long-Term Evaluation of Patients Experiencing Virologic Failure of a Protease Inhibitor Containing Regimen Who Choose to Temporarily Discontinue Therapy
Long-Term Evaluation of Patients Experiencing Virologic Failure of a Protease Inhibitor Containing Regimen Who Choose to Temporarily Discontinue Therapy
Abstract
-
Implementing a Sampling-based Approach to Measuring Patient Outcomes Among HIV-infected Patients Lost to Follow-up in East Africa: the I-SAMPOLE Study
Implementing a Sampling-based Approach to Measuring Patient Outcomes Among HIV-infected Patients Lost to Follow-up in East Africa: the I-SAMPOLE Study
Abstract
The science of implementation begins with the ability to measure important occurrences in routine, day-to-day clinical care. Although the provision of care and treatment for HIV-infected patients in Africa over the last five years has scaled up rapidly, loss to follow-up (i.e., unknown outcomes) commonly exceeds 40% at 1 year. By precluding knowledge of key events, such as mortality and retention in care, losses systematically impair our ability to measure occurrences in clinical care for the conduct implementation science.
-
REACH Cohort Adherence-Pharmacokinetic Substudy
REACH Cohort Adherence-Pharmacokinetic Substudy
Abstract
Publications:
-
A Placebo-Controlled Pilot Study of Chinese Herbs in HIV Associated Cryptosporidium-Negative Diarrhea
A Placebo-Controlled Pilot Study of Chinese Herbs in HIV Associated Cryptosporidium-Negative Diarrhea
Abstract
-
Integrated Regulatory Mechanisms Controlling HIV-Associated Immune Activation
Integrated Regulatory Mechanisms Controlling HIV-Associated Immune Activation
Abstract
Chronic immune activation is a significant determinant of HIV-mediated CD4+ T cell loss and disease progression. Despite effective viral suppression, chronic inflammation persists at levels higher than in uninfected people, yet the inflammatory stimuli and the mechanisms by which inflammation persists and promotes disease pathology are not completely understood. Many mechanisms likely contribute to chronic immune activation including persistent antigenemia, depletion of T regulatory cells (Tregs), and stimulation of toll-like receptors.
-
It Takes a Village: Community Engagement in San Francisco and Kisumu to reduce HIV risk in Homeless Youth and Street Children
It Takes a Village: Community Engagement in San Francisco and Kisumu to reduce HIV risk in Homeless Youth and Street Children
Abstract
My research has consistently focused on the effects of poverty and of social/cultural context on the health of our most disadvantaged youth, particularly homeless youth in San Francisco and street children in Kisumu, Kenya. Through my work in San Francisco since 2001, I demonstrated the feasibility of longitudinal epidemiological work with street youth, demonstrated the role of street culture, social networks and race in HIV risk of street youth, and developed a community collaborative project for street-based STI testing of street youth.
-
Effect of the Timing of HIV Infection Treatment on the Reconstitution of the T Cell Receptor Repertoire
Effect of the Timing of HIV Infection Treatment on the Reconstitution of the T Cell Receptor Repertoire
Abstract
CD4+ T cell depletion is a hallmark of HIV infection and the CD4+ T cell count is useful for staging patients as they progress to AIDS. However, a bulk lymphocyte count does not take into account the diversity of recognition specificities these T cells have. Using a novel quantitative assay of T cell receptor (TCR) genetic diversity, called AmpliCot, we have found that untreated HIV infection is associated with an order of magnitude decrease in blood T cell diversity and that these decreases correlate with CD4+ counts.
-
Mobilizing the Humoral Immune Response against Human Endogenous Retroviruses to Control HIV-1 Viral Replication
Mobilizing the Humoral Immune Response against Human Endogenous Retroviruses to Control HIV-1 Viral Replication
Abstract
One reason HIV-1-infected subjects fail to control viremia is due to the high rate of mutation of HIV-1, with consequent escape from the immune response, especially from neutralizing antibodies. Approximately 8% of the human genome is composed of human endogenous retroviruses (HERVs). Most HERVs are fixed in the human genome, defective in replication, and transcriptionally silent in normal cells. Previous studies have shown members of the HERV-K (HK) family are reactivated during HIV-1 infection.